Chemical | 16 February 2021
Neogen Chemicals Q3FY21 consolidated PAT up at Rs. 8.53 Cr
The company posted net profit of Rs.8.07 crores for the period ended December 31, 2019.
The company posted net profit of Rs.8.07 crores for the period ended December 31, 2019.
Chemical companies invested in IT infrastructure, which helped them save operating and administration costs.
bp will work with IBM to explore using quantum computing to solve business and engineering challenges and explore the potential applications for driving efficiencies and reducing carbon ?emissions
Shell’s strategy will rebalance its portfolio, investing annually $5-6 billion in its growth pillar
The increase in revenues in polyurethanes segment was primarily due to higher MDI average selling prices.
The company posted net profit of Rs.137.9 crores for the period ended December 31, 2019.
The Propylene Derivative Petrochemical Project (PDPP) will help strengthen India’s journey towards being Aatmanirbhar.
The company posted net loss of Rs. 3.80 crores for the period ended December 31, 2019.
The company posted net profit of Rs.8.01 crores for the period ended December 31, 2019.
The jump in profit is due to the better performance of the API business.
Elementis's personal care business will exclusively sell Aqdot's odor capture and smart fragrance solution Perspirant and Deodorant Formulators
The new plants join two existing ASUs, also built and operated by Linde, to support phase I and II of Wanhua Chemical's integrated chemical site and production center in Yantai, China
The transaction is expected to be completed in the second half of 2021.
The change will enable an enhanced customer centered approach, management focus and decision-making, strengthened resource allocation, and increased transparency and accountability as per the company
The company is setting up greenfield BOPET and CPP lines in Karnataka to meet the growing demand.
The company has posted net profit of Rs.2301.31 crores for the 9 months period ended December 31, 2020
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
The company posted net profit of Rs.35.82 crores for the period ended December 31, 2019.
The company has posted net profit loss of Rs. 3.78 crores for the period ended December 31, 2019.
Subscribe To Our Newsletter & Stay Updated
